DiogenX is a preclinical stage biotech company committed to discovering and developing innovative biologics as new therapeutic options for diabetic patients around the world.

DiogenX

DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits.DiogenX is headquartered in Marseille, with labs in Nice (France).

COM:DIOGENX

DiogenX

Filings Not Available